Todd D. Schell

Pennsylvania State University College of Medicine

H指数:33

被引数:4,122

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PD-1 regulates CD4+ T cell-mediated CD8+ T cell responses in the brain to balance viral control and neuroinflammation

PD-1调节脑内CD4+ T细胞介导的CD8+ T细胞反应以平衡病毒控制和神经炎症

Nature Communications

IF15.7

2026-08-170

OAAI

Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth

靶向VPS4通过STING介导的抗肿瘤免疫抑制横纹肌肉瘤生长

Oncogene

IF7.3

2026-04-240

OAAI

IGF2BP1 fosters an immunosuppressive tumor microenvironment in high-risk neuroblastoma, contributing to their resistance to immunotherapy

IGF2BP1促进高风险神经母细胞瘤的免疫抑制性肿瘤微环境，导致其对免疫治疗产生抵抗。

OncoImmunology

IF6.3

2025-12-020

OAAI

The Effects of Co-Exposure of Tobacco Smoke with Dibenzo[a,l]pyrene Diol Epoxide on Molecular Targets and Immune Cells in the Mouse Oral Cavity

烟草烟雾与二苯并[a,l]芘二醇环氧化物联合暴露对小鼠口腔分子靶点及免疫细胞的影响

Chemico-Biological Interactions

IF5.4

2025-08-050

OAAI

Managing telomerase and telomere dysfunction in acral melanoma

管理肢端黑色素瘤中的端粒酶和端粒功能障碍

PHARMACOLOGICAL RESEARCH

IF10.5

2025-05-011

OAAI

Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity

工程化人树突状细胞诱导的细胞毒性淋巴细胞介导强大的抗白血病活性

CANCER IMMUNOLOGY IMMUNOTHERAPY

IF5.1

2025-02-250

Current challenges and potential opportunities for interception and prevention of head and neck cancer

头颈癌的拦截与预防所面临的当前挑战和潜在机遇

CARCINOGENESIS

IF2.9

2025-02-010

PRE

Optogenetically engineered Septin-7 enhances immune cell infiltration of tumor spheroids

光遗传工程Septin-7增强肿瘤球体的免疫细胞浸润

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2024-10-230

PRE

Identification of Novel Isatin Derivative Bearing a Nitrofuran Moiety as Potent Multi-Isoform Aldehyde Dehydrogenase Inhibitor

鉴定带有硝基呋喃部分的新型靛红衍生物作为有效的多同工型醛脱氢酶抑制剂

MOLECULES

IF4.6

2024-06-292

OAAI

Pharmacological agents targeting drug-tolerant persister cells in cancer

PHARMACOLOGICAL RESEARCH

IF10.5

2024-05-013

OAAI

Immune Responses in Oral Papillomavirus Clearance in the MmuPV1 Mouse Model

PATHOGENS

IF3.3

2023-12-144

OAAI

Sexually dimorphic effect of H-ferritin genetic manipulation on survival and tumor microenvironment in a mouse model of glioblastoma

JOURNAL OF NEURO-ONCOLOGY

IF3.1

2023-10-091

PRE

Complementarity between Microbiome and Immunity May Account for the Potentiating Effect of Quercetin on the Antitumor Action of Cyclophosphamide in a Triple-Negative Breast Cancer Model

PHARMACEUTICALS

IF4.8

2023-10-065

OAAI

Novel fourth generation-like CARmiR cells release therapeutic miRNA via exosomes and enhance glioblastoma cell killing activity

BIOCHEMICAL ENGINEERING JOURNAL

IF3.8

2023-10-012

PRE

Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model

JOURNAL OF IMMUNOLOGY

IF3.4

2023-09-152

PRE

IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-07-1222

OAAI

Schweinfurthin induces ICD without ER stress and caspase activation

ONCOIMMUNOLOGY

IF6.3

2022-08-038

Drug-Tolerant Persister Cells in Cancer Therapy Resistance

CANCER RESEARCH

IF16.6

2022-05-1846

Adoptive transfer of cytotoxic lymphocytes generated by engineered human dendritic cells for AML treatment

CANCER RESEARCH

IF16.6

2020-08-150

PRE

A pilot clinical trial to study the effects of Angelica gigas dietary supplement (Cognl.Q) on human immune cells (NCT03630328)

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Todd D. Schell

个人简介

教育背景

工作经历

荣誉奖项

研究方向